Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis
ConclusionConbercept had a higher rate of primary cure in ROP patients. More RCTs are needed to compare the efficacy of conbercept and ranibizumab in treating ROP.
Source: International Journal of Clinical Pharmacy - Category: Drugs & Pharmacology Source Type: research
More News: China Health | Databases & Libraries | Drugs & Pharmacology | Eyes | Lucentis | Ranibizumab Injection | Science | Statistics | Study